These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 9169967)

  • 1. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review.
    Lane R; Baldwin D
    J Clin Psychopharmacol; 1997 Jun; 17(3):208-21. PubMed ID: 9169967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.
    Sproule BA; Naranjo CA; Brenmer KE; Hassan PC
    Clin Pharmacokinet; 1997 Dec; 33(6):454-71. PubMed ID: 9435993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serotonin syndrome with fatal outcome caused by selective serotonin reuptake inhibitors].
    Apelland T; Gedde-Dahl T; Dietrichson T
    Tidsskr Nor Laegeforen; 1999 Feb; 119(5):647-50. PubMed ID: 10095385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated venlafaxine-induced serotonin syndrome.
    Kolecki P
    J Emerg Med; 1997; 15(4):491-3. PubMed ID: 9279702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically significant drug interactions with antidepressants in the elderly.
    Spina E; Scordo MG
    Drugs Aging; 2002; 19(4):299-320. PubMed ID: 12038880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serotonin syndrome. Implicated drugs, pathophysiology and management.
    Sporer KA
    Drug Saf; 1995 Aug; 13(2):94-104. PubMed ID: 7576268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary management of depression.
    Andrews JM; Nemeroff CB
    Am J Med; 1994 Dec; 97(6A):24S-32S. PubMed ID: 7992823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin syndrome: a complex but easily avoidable condition.
    Dvir Y; Smallwood P
    Gen Hosp Psychiatry; 2008; 30(3):284-7. PubMed ID: 18433663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin syndrome and drug combinations: focus on MAOI and RIMA.
    Hilton SE; Maradit H; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(3):113-9. PubMed ID: 9224903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin syndrome.
    Bodner RA; Lynch T; Lewis L; Kahn D
    Neurology; 1995 Feb; 45(2):219-23. PubMed ID: 7854515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin syndrome.
    Mills KC
    Am Fam Physician; 1995 Oct; 52(5):1475-82. PubMed ID: 7572570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions with selective serotonin reuptake inhibitors, especially with other psychotropics.
    Prescrire Int; 2001 Feb; 10(51):25-31. PubMed ID: 11503857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin toxicity: a short review of the literature and two case reports involving citalopram.
    Talarico G; Tosto G; Pietracupa S; Piacentini E; Canevelli M; Lenzi GL; Bruno G
    Neurol Sci; 2011 Jun; 32(3):507-9. PubMed ID: 21491099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology.
    Goodnick PJ; Goldstein BJ
    J Psychopharmacol; 1998; 12(3 Suppl B):S5-20. PubMed ID: 9808077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.